Corporacion Sanitaria Parc Tauli

Treatment & access

• Treatments offeredEsketamine nasal spray (Spravato®)
• Access routeTrial
• Cost & coverage (registry status)Free within clinical trial
• Websitehttps://www.tauli.cat

About this provider

Compiled from the registry data on this page.

This entry describes a clinical trial site: Corporacion Sanitaria Parc Tauli, Sabadell, Barcelona, Spain. The site takes part in CTIS trial 2024-512672-34-00, the CESAR study comparing esketamine nasal spray with aripiprazole, both combined with an antidepressant, in refractory major depression (RMDD) in elderly patients (sponsor: Fundacion Publica Andaluza Para La Gestion De La Investigacion En Salud De Sevilla). The treatment studied is esketamine (Spravato); access runs through enrolment in the trial, and participation is free of charge within it. The CTIS public record in the EU Clinical Trials Information System is the registry source cited. Last verification of this entry: 2026-07-29.

9 more verified providers within 50 km

• Granollers · 16 kmFundació Hospitalàries Sant Boi_Granollers : Clinical trials
• Barcelona · 19 kmClínica Synaptica : Ketamine / KAP
• Barcelona · 19 kmHospital Clínic Barcelona — Unidad de Trastornos Bipolares y Depresivos : Spravato®

See them on the provider map →

What to prepare before you enquire

• A referral or the contact details of your treating clinician
• A list of medications you have tried (names, doses, duration)
• A short diagnosis summary or discharge letters

The research team confirms eligibility against your medical records at a screening visit.

Send documents directly to the provider when they reply. We never ask you to upload medical records.